ZA80501B - Method for producing 6,7-dimethoxy-4-amino-2-(4-(2-furoyl)-1-piperazinyl)quinazoline hydrochloride having an antihypertensive effect - Google Patents
Method for producing 6,7-dimethoxy-4-amino-2-(4-(2-furoyl)-1-piperazinyl)quinazoline hydrochloride having an antihypertensive effectInfo
- Publication number
- ZA80501B ZA80501B ZA00800501A ZA80501A ZA80501B ZA 80501 B ZA80501 B ZA 80501B ZA 00800501 A ZA00800501 A ZA 00800501A ZA 80501 A ZA80501 A ZA 80501A ZA 80501 B ZA80501 B ZA 80501B
- Authority
- ZA
- South Africa
- Prior art keywords
- furoyl
- piperazinyl
- dimethoxy
- amino
- producing
- Prior art date
Links
- 230000003276 anti-hypertensive effect Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- WFXFYZULCQKPIP-UHFFFAOYSA-N prazosin hydrochloride Chemical compound [H+].[Cl-].N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1=CC=CO1 WFXFYZULCQKPIP-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Furan Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI790320A FI67699C (fi) | 1979-01-31 | 1979-01-31 | Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA80501B true ZA80501B (en) | 1981-02-25 |
Family
ID=8512343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA00800501A ZA80501B (en) | 1979-01-31 | 1980-01-28 | Method for producing 6,7-dimethoxy-4-amino-2-(4-(2-furoyl)-1-piperazinyl)quinazoline hydrochloride having an antihypertensive effect |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4271300A (et) |
| JP (1) | JPS55104280A (et) |
| AT (1) | AT374475B (et) |
| BE (1) | BE881297A (et) |
| CA (1) | CA1128945A (et) |
| CH (1) | CH644605A5 (et) |
| CS (1) | CS214692B2 (et) |
| DD (1) | DD148952A1 (et) |
| DE (1) | DE3002553A1 (et) |
| DK (1) | DK158352C (et) |
| FI (1) | FI67699C (et) |
| FR (1) | FR2447920A1 (et) |
| GB (1) | GB2041932B (et) |
| HU (1) | HU181016B (et) |
| NL (1) | NL190701C (et) |
| NO (1) | NO152298C (et) |
| PL (1) | PL126994B1 (et) |
| SE (1) | SE430692B (et) |
| SU (1) | SU900812A3 (et) |
| YU (1) | YU41498B (et) |
| ZA (1) | ZA80501B (et) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI70411C (fi) * | 1980-12-29 | 1986-09-19 | Pfizer | Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat |
| FI79107C (fi) * | 1984-06-25 | 1989-11-10 | Orion Yhtymae Oy | Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid. |
| US4601897A (en) * | 1985-11-06 | 1986-07-22 | Pfizer Inc. | Prazosin-pirbuterol combination for bronchodilation |
| AT384218B (de) * | 1985-12-04 | 1987-10-12 | Gerot Pharmazeutika | Verfahren zur herstellung von neuen chinazolin-derivaten |
| YU70890A (en) * | 1989-04-21 | 1992-05-28 | Egyt Gyogyszervegyeszeti Gyar | Process for obtaining quinazoline derivatives |
| CA2077252C (en) * | 1992-08-31 | 2001-04-10 | Khashayar Karimian | Methods of making ureas and guanidines, and intermediates therefor |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3511836A (en) * | 1967-12-13 | 1970-05-12 | Pfizer & Co C | 2,4,6,7-tetra substituted quinazolines |
| GB1390014A (en) * | 1971-05-07 | 1975-04-09 | Koninklijke Pharma Fab Nv | Process for the preparation of carbocyclic fused pyrimidine derivatives |
| US3935213A (en) * | 1973-12-05 | 1976-01-27 | Pfizer Inc. | Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives |
| US4092315A (en) * | 1976-03-01 | 1978-05-30 | Pfizer Inc. | Novel crystalline forms of prazosin hydrochloride |
| FI58124C (fi) * | 1976-12-15 | 1980-12-10 | Orion Yhtymae Oy | Ny mellanprodukt 3,4-dimetoxi-6-(4-(2-furoyl)-1-piperazinyltiokarbamido)-bensonitril foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolin med blodtryckssaenkande verkan |
| FI58125C (fi) * | 1976-12-15 | 1985-01-02 | Orion Yhtymae Oy | Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolin med blodtryckssaenkande vekan |
-
1979
- 1979-01-31 FI FI790320A patent/FI67699C/fi not_active IP Right Cessation
- 1979-12-27 NO NO794279A patent/NO152298C/no unknown
-
1980
- 1980-01-09 CH CH12180A patent/CH644605A5/de not_active IP Right Cessation
- 1980-01-09 US US06/110,589 patent/US4271300A/en not_active Expired - Lifetime
- 1980-01-09 CA CA343,361A patent/CA1128945A/en not_active Expired
- 1980-01-10 YU YU58/80A patent/YU41498B/xx unknown
- 1980-01-15 AT AT0019580A patent/AT374475B/de not_active IP Right Cessation
- 1980-01-16 NL NL8000289A patent/NL190701C/xx not_active IP Right Cessation
- 1980-01-23 BE BE0/199070A patent/BE881297A/fr not_active IP Right Cessation
- 1980-01-25 DE DE19803002553 patent/DE3002553A1/de active Granted
- 1980-01-28 ZA ZA00800501A patent/ZA80501B/xx unknown
- 1980-01-28 CS CS80588A patent/CS214692B2/cs unknown
- 1980-01-29 HU HU8080182A patent/HU181016B/hu not_active IP Right Cessation
- 1980-01-29 GB GB8002903A patent/GB2041932B/en not_active Expired
- 1980-01-30 JP JP1081580A patent/JPS55104280A/ja active Granted
- 1980-01-30 PL PL1980221684A patent/PL126994B1/pl unknown
- 1980-01-30 SU SU802874898A patent/SU900812A3/ru active
- 1980-01-30 FR FR8001991A patent/FR2447920A1/fr active Granted
- 1980-01-31 DD DD80218776A patent/DD148952A1/de not_active IP Right Cessation
- 1980-01-31 DK DK042680A patent/DK158352C/da not_active IP Right Cessation
- 1980-01-31 SE SE8000777A patent/SE430692B/sv unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU181016B (en) | 1983-05-30 |
| NL190701B (nl) | 1994-02-01 |
| GB2041932A (en) | 1980-09-17 |
| SU900812A3 (ru) | 1982-01-23 |
| FI67699C (fi) | 1985-05-10 |
| JPS6310955B2 (et) | 1988-03-10 |
| DD148952A1 (de) | 1981-06-17 |
| FI67699B (fi) | 1985-01-31 |
| ATA19580A (de) | 1983-09-15 |
| NO152298B (no) | 1985-05-28 |
| CH644605A5 (de) | 1984-08-15 |
| BE881297A (fr) | 1980-05-16 |
| DK42680A (da) | 1980-08-01 |
| AT374475B (de) | 1984-04-25 |
| US4271300A (en) | 1981-06-02 |
| DK158352B (da) | 1990-05-07 |
| YU5880A (en) | 1983-02-28 |
| PL221684A1 (et) | 1980-10-20 |
| JPS55104280A (en) | 1980-08-09 |
| FR2447920B1 (et) | 1982-12-03 |
| CS214692B2 (en) | 1982-05-28 |
| PL126994B1 (en) | 1983-09-30 |
| FI790320A (fi) | 1980-08-01 |
| DE3002553A1 (de) | 1980-08-07 |
| YU41498B (en) | 1987-08-31 |
| NO794279L (no) | 1980-08-01 |
| CA1128945A (en) | 1982-08-03 |
| GB2041932B (en) | 1982-10-27 |
| DE3002553C2 (et) | 1988-10-27 |
| NL8000289A (nl) | 1980-08-04 |
| DK158352C (da) | 1990-10-08 |
| NL190701C (nl) | 1994-07-01 |
| FR2447920A1 (fr) | 1980-08-29 |
| NO152298C (no) | 1985-09-04 |
| SE430692B (sv) | 1983-12-05 |
| SE8000777L (sv) | 1980-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU517636B2 (en) | 1 (4-amino-6, 7-dimethoxy-2-quinazolinyl) 4 (2 tetrahydrofuroyl) piperazine hydrochloride dihydrate | |
| YU312781A (en) | Process for obtaining 4-amino-6,7-dimethoxy-2-piperazine quinazoline | |
| DK262980A (da) | Fremgangsmaade til fremstilling af 2,3-dihydro-2,6,7-trisubstituerede 5-acylbenzofuraner | |
| YU41294B (en) | Process for obtaining the crystalline alpha-from of 2-(4(2-furoy)-piperazione-1-yl)-4-amino-6,7-dimethoxy quinazoline hydroclorides | |
| FI852765A0 (fi) | Foerfarande foer framstaellning av saosom hjaertmedicin anvaendbara 1,6-naftyridin 2(1h)-oner. | |
| ZA80501B (en) | Method for producing 6,7-dimethoxy-4-amino-2-(4-(2-furoyl)-1-piperazinyl)quinazoline hydrochloride having an antihypertensive effect | |
| YU39155B (en) | Process for obtaining 2-(4-aroylpiperazine-1-yl)-4-amino-6,7-dimethoxy quinazolines | |
| ZA777223B (en) | Method for the production of 6,7-dimethoxy-4-amino-2-(4-(2-furoyl)-1-piperazinyl)quinazoline having an antihypertensive effect | |
| MY8200110A (en) | 4-amino-6,7-dimethoxy-2-[4-(heterocy-clocarbonyl)piperazin-1-yl]quinazolines | |
| YU171577A (en) | Process for obtaining 2-(4-(2-furoyl)piperazine-1-yl)4-amino-6,7-dimethoxy-quinazoline | |
| YU36180A (en) | Process for producing the crystalline form of 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)-piperazine hydrochloride | |
| YU43835B (en) | Process for obtaining crystalline 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)-piperazine hydrochloride | |
| ZA777222B (en) | An intermediate product for the production of 6,7-dimethoxy-4-amino-2-(4-(furoyl)-1-piperazinyl)quinazoline having an antihypertensive effect | |
| IT8320738A0 (it) | Procedimento per produrre 2,3-diidro-2,2-dimetil-7-benzofuranolo. | |
| BG47571A1 (en) | Method for preparing of crystal alpha- form of 1- (4- amino- 6, 7- dimetoxy- 2- quinazolinyl)- 4- (2- furoyl)- piperazine hydrochloride | |
| BG42903A1 (en) | Method for preparing crystal alpha form of 1- (4- amino- 6, 7- dimetoxy- 2- quanazolyl)- 4- (2- furoyl)- piperazine hydrochloride | |
| DK435085A (da) | Fremgangsmaade til fremstilling af 5,6-dialkoxy-4-alkyl-2(1h)-quinazolinoner | |
| RO88729A2 (ro) | Procedeu de obtinere a 0,0-dialchil-0-(2,3-dihidro-2,2-dimetil-5-r-7-benzofuranil)-fosforotioatilor | |
| PH15619A (en) | 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate |